Freespirited Drinks, a start-up producing non-alcoholic spirits under the brand “REBELS 0.0%”, has just closed its seed financing round in the amount of CHF 1 million. The funding will be used to accelerate the expansion into key
Tags :Wenger & Vieli
Scandit, smart data capture platform, has completed a USD 150m Series D financing round at a company valuation in excess of USD 1billion. The oversubscribed round was led by Warburg Pincus and also included strong
Jakob Müller Holding, a Swiss OEM for the textile industry, has sold TexTrace to Avery Dennison Corporation. TexTrace is a technology developer specialising in bespoke woven and knitted RFID products integrated into garments. The
Malvern Panalytical, an England based company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has completed the acquisition of Creoptix, a specialist
Sequotech Group, a Swiss group of specialized IT services companies, has acquired Uditis, a company also active in the domain of information systems. The acquisition of Uditis will allow the group to further expand its
Sygnum Bank, a digital asset technology group with a Swiss banking license and a Singapore asset management licence, has raised USD 90 million in an oversubscribed Series B funding round led by Sun Hung Kai Strategic
Kandou, an innovator in high-speed, energy-efficient, chip link solutions, closed its Series D round of funding, resulting in USD 75 million raised in the round. To date, the total investment in Kandou is USD 207.8 million from
Klingel medical metal group, owned by the IK Partners’ funds, has entered into a definitive agreement to acquire Ruetschi Technology Holding. Ruetschi is a full service provider of sterile packaged single-use medical devices with focus
YouGov, the international market research and data analytics group, has entered into a definitive agreement to acquire Bre Holding, Zug, including its 100% subsidiary Link Marketing Services, Lucerne, a Swiss market and social research agency.
The European Investment Bank (EIB) has signed a EUR 15 million quasi-equity financing agreement with Xeltis, a Swiss-Dutch medtech firm developing medical devices enabling cardiovascular restoration. The EIB’s non-dilutive financing will support the acceleration of
